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Improved results in pancreas transplantation using the whole organ and a 
duodenal segment for diversion of exocrine secretion (1,2) led to the introduc-
tion of this technique at the Munich Transplant Centre, too. This technique 
permits monitoring of the pancreatic exocrine secretion in the urine. There is 
accumulating Suggestion that reduction in urine amylase activity might be an 
early marker of pancreatic allograft rejection. As an extension to our experience 
with the duct-occlusion technique we started a controlled study comparing both 
surgical techniques. 
Patients and methods 
So far 91 combined pancreas and kidney transplantation and 7 isolated 
pancreas transplantations have been performed using prolamine for duct 
occlusion. The bladder drainage technique was used in 16 diabetics, 11 
simultaneously and 5 pancreas alone. Clinical results of our experience with the 
duct-occlusion technique have been published elsewhere (3). 
Donor and recipient Operation 
The whole pancreas with spieen and a short duodenal segment is removed from 
the donor after complete in situ flushing using UW Solution. In 4/16 organ 
procurements we harvested the whole pancreas together with the liver for 
grafting. Priority of vascular supply was given to the liver, consisting of the 
celiac axis plus an aortic patch and the portal vein. The whole pancreas graft 
includes the splenic artery, divided just distal to its origin on the celiac axis, 
superior mesenteric artery with an aortic patch and the remaining portal vein 
plus the superior mesenteric vein. After the Kocher maneuver a short duodenal 
segment is provided using a GIA Stapler. The combined removal of liver and 
whole pancreas requires an arterial and venous reconstruction for the pan-
creatico- duodenal graft with the donor iliac vessels (4). The pancreatico-
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duodenal graft is placed intraperitoneally along the ascending colon with a 
transrectal incision. Arterial and venous anastomoses were carried out between 
the reconstruction pancreatic vessels and the recipient's external iliac vessels. 
For the bladder-duodenal anastomosis we use the two layer side-to-side 
technique (inner layer: running: 3/0 Vicryl and outer layer: interrupted 3/0 
Vicryl). 
Immunosuppressive protocol 
Since 1984 a quadruple drug induction therapy is routinely used in pancreatic 
transplantation. It consists of CsA, Aza 'high' dose of steriods and ATG/ALG 
for a short period of time. Maintenance treatment consists of steriods, CsA and 
Aza for a period of 6 months, followed by double drug maintenance treatment 
with CsA and Aza. 
More recently we have used a quadruple drug induction therapy with CsA, 
Aza, 'high' dose of steriods and ATG or OKT3 in a controlled study. The 
preliminary results were presented in Barcelona (5). 
Problems and complications according to diflerent surgical techniques 
Using the duct-occlusion technique we are confronted with two major Prob-
lems. Firstly, the occurrence of a primary irreversible venous thrombosis. 
Secondly, the development of a pancreatic fistula with the high risk of a 
secondary infection. The rate of this complication is shown in Table 1. The 
need of an anticoagulation therapy is required. 
Despite of duct-occlusion with prolamine the residual exocrine secretion 
remains unsolved at the present time. 
According to the new technique our clinical results show a hight incidence of 
intraparanchymal graft abscesses with subsequent loss of the pancreatic graft 
Table 1. Early complications after stimultaneous pancreas and kidney transplantation. 
Surgical 
technique 
Venous 
thrombosis 
Local infection 
Intragraft Perigraft 
Pancreatic 
fistula 
Dust 15% 0 20% 20% 
occlusion ( n - 9 ) (" = 12) (" = 12) 
( " - 5 9 ) 
Bladder 0 36% 18% 0 
drainage ( / i - 4 ) ( n - 2 ) 
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(Table 1). This complication is very common in association with an urinary tract 
infection. 
Results 
Patients and graft survival probability rates for 1 year are comparable in both 
groups (Figures 1 and 2). Long-term results are demonstrable for the duct 
occlusion technique oniy (Figure 3). 
Summary 
Mortality and morbidity rates after pancreas transplantation are low and 
comparable in both groups talking into account that the number of patients 
transplanted using the bladder technique is still low and the Observation period 
limited. The 1-year pancreas graft function rate is 60% in both groups. The 
early phase post-transplant using the duct obliteration in a segmental allograft 
bears the risk of an irreversible venous thrombosis and the development of a 
pancreatic fistula with subsequent graft loss. As a consequence of prolamine, 
Simultaneous Pancreas and Kidney Transplantation 
using the Duct-Occlusion Technique (n=53) Group II 
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Fig. 1. Patients and graft survival probability in stimultaneous pancreas and kidney transplanta-
tion using the duct-occlusion techniques (n = 53) (Cutler/Ederer formula). 
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Fig. 2. Patient and graft survival probability in combined pancreas and renal transplantation 
using the bladder-drainage technique (n = 11) (Cutler/Ederer formula). 
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Fig. 3. Long-term results in simultaneous pancreas and kidney transplantation in duct-occluded 
segmental allografts (n = 100) (Cutler/Ederer formula). 
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the result in the long-run is a vascularized islet cell graft without any exocrine 
activity and with no risk for the recipient. The induced destruction of exocrine 
tissue by prolamine is not associated with a deterioration of the endocrine 
function. Our early clinical observations with the bladder drainage show a 
remarkably high rate of local infection-complication following urinary tract 
infection also with subsequent graft loss. Patients with a history of bladder 
dysfunction as a side effect of long-term diabetic disease might therefore be 
better candidates for the duct-occlusion technique. 
The surgical complication rate is acceptable. Still unsolved is the problem of 
a transplanted gland with an aggressive enzymatic secretion at the bladder 
mucosa, as well as for the recipient himself. With this technique postoperative 
complications may not only develop on the side of the pancreas but also from 
the duodenal segment. Further experience and long-term results must be gained 
to find out the best surgical technique. 
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